3/21
12:22 pm
mrna
Rating for MRNA
Low
Report
Rating for MRNA
3/13
09:43 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
3/13
09:43 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
3/13
08:23 am
mrna
Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $40.00 price target on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $40.00 price target on the stock.
3/13
06:15 am
mrna
Moderna initiated with a Neutral at Citi
Low
Report
Moderna initiated with a Neutral at Citi
2/19
09:37 am
mrna
Rating for MRNA
Low
Report
Rating for MRNA
2/18
04:03 pm
mrna
Moderna, Inc. (NASDAQ: MRNA) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
2/18
04:03 pm
mrna
Moderna, Inc. (NASDAQ: MRNA) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
Low
Report
Moderna, Inc. (NASDAQ: MRNA) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
2/18
12:39 pm
mrna
Rating for MRNA
Low
Report
Rating for MRNA
2/18
12:39 pm
mrna
Rating for MRNA
Low
Report
Rating for MRNA
2/18
08:28 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
2/18
08:28 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
2/18
07:37 am
mrna
Moderna, Inc. (NASDAQ: MRNA) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $45.00 price target on the stock, down previously from $111.00.
Medium
Report
Moderna, Inc. (NASDAQ: MRNA) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $45.00 price target on the stock, down previously from $111.00.
2/18
06:10 am
mrna
Moderna downgraded to Equal Weight from Overweight at Barclays
Medium
Report
Moderna downgraded to Equal Weight from Overweight at Barclays
2/18
06:10 am
mrna
Moderna downgraded to Equal Weight from Overweight at Barclays
Medium
Report
Moderna downgraded to Equal Weight from Overweight at Barclays
1/27
10:27 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA
1/15
09:52 am
mrna
Rating for MRNA
Low
Report
Rating for MRNA
1/15
09:52 am
mrna
Rating for MRNA
Low
Report
Rating for MRNA
1/8
10:03 am
mrna
Rating for MRNA
Medium
Report
Rating for MRNA